(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RADICAVA ORS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

RADICAVA ORS

ST13

US500000079298102

Class

5

Filing

79298102

Registration

6422491

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

07/20/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

09/15/2020

Registration date

07/20/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/20/2021

Last transaction

07/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

JP

Examiner

SOBRAL, CHRISTINA

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

K.K. BCJ-94
M. C. (pessoa física)

Representatives

Jeffrey L. Costellia Nixon Peabody LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); pharmaceutical preparations for the treatment of acute ischemic stroke

Publications

History of USPTO decisions and trademark events.

26 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/20/2026

DCPN

CHANGE OF OWNER RECEIVED FROM IB

01/01/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/06/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/17/2021

FIMP

FINAL DISPOSITION PROCESSED

11/17/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/20/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

07/20/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/04/2021

PUBO

PUBLISHED FOR OPPOSITION

05/04/2021

GPNX

NOTIFICATION PROCESSED BY IB

05/03/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/14/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/14/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/14/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/25/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/24/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/24/2021

RFNT

REFUSAL PROCESSED BY IB

03/01/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/07/2021

RFRR

REFUSAL PROCESSED BY MPU

02/07/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/29/2021

CNRT

NON-FINAL ACTION WRITTEN

01/28/2021

DOCK

ASSIGNED TO EXAMINER

01/28/2021

MAFR

APPLICATION FILING RECEIPT MAILED

11/24/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/20/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/19/2020

Continuous trademark protection

Get notified about every new filing that threatens RADICAVA ORS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.